A leading provider of healthcare communication and interpretation services, delivering HIPAA- compliant, technology-enabled solutions to hospitals, health systems, and managed care organizations across the U.S.

The Company provides medical video remote interpreting (VRI), telephonic interpretation, document translation, and on-site interpretation services, supported by a workforce of 550+ professionals and delivering more than 3.5 million interpretation minutes per month.

Founded 2019. 550+ workforce delivering 3.5M+ monthly interpretation minutes. 95%+ healthcare revenue concentration with long-term contracted clients.

Key Investment Highlights

• $10.3M revenue in 2025, with $11.5M+ projected revenue for 2026
• $2.3M EBITDA in 2025, representing a 22% EBITDA margin
• 95%+ of revenue generated from healthcare clients
• Long-term relationships with hospitals, health systems, and managed care organizations
• HIPAA and SOC II Type II certified infrastructure
• Capital-light and scalable operating model
• 550+ workforce and 3.5M+ monthly interpretation minutes
• Strong organic growth achieved without acquisitions

Growth Opportunities

The Company has significant potential for further expansion through health system and payer relationships, telehealth partnerships, geographic expansion, new service verticals, AI integration, and M&A.

Transaction Opportunity

The shareholders are considering a majority recapitalization, strategic partnership, or full acquisition to support the Company’s next stage of growth. Additional information is available to qualified parties following execution of an NDA.

DISCLAIMER

The information contained in this listing is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security or business entity. Access to detailed financial data, target identification, and the Confidential Information Memorandum (CIM) is strictly contingent upon the prior execution of:

1. A Non-Disclosure Agreement (NDA) to protect the target company’s proprietary and sensitive business information.
2. A Buy-Side Fee Agreement governing the advisor/intermediary compensation structure upon the successful closing of a transaction.

No confidential or identifying information will be released prior to the full execution of both agreements by an authorized representative of the buyer.